These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

904 related items for PubMed ID: 22884884

  • 1. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM, Chen S, Al-Mahtab M, Abe M, Hiasa Y, Onji M.
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [Abstract] [Full Text] [Related]

  • 2. Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection.
    Akbar SM, Yoshida O, Chen S, Cesar AJ, Abe M, Matsuura B, Hiasa Y, Onji M.
    Antivir Ther; 2010 Oct; 15(6):887-95. PubMed ID: 20834101
    [Abstract] [Full Text] [Related]

  • 3. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P, Dembek C, Kuklick L, Jäger C, Tedjokusumo R, von Freyend MJ, Drebber U, Janowicz Z, Melber K, Protzer U.
    Vaccine; 2013 Feb 06; 31(8):1197-203. PubMed ID: 23306359
    [Abstract] [Full Text] [Related]

  • 4. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM, Furukawa S, Hasebe A, Horiike N, Michitaka K, Onji M.
    Int J Mol Med; 2004 Aug 06; 14(2):295-9. PubMed ID: 15254781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp.
    Farag MM, Tedjokusumo R, Flechtenmacher C, Asen T, Stremmel W, Müller M, Protzer U, Weigand K.
    Vaccine; 2012 Sep 14; 30(42):6034-9. PubMed ID: 22867720
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
    Wang S, Qiu L, Liu G, Li Y, Zhang X, Jin W, Gao GF, Kong X, Meng S.
    Vaccine; 2011 Aug 26; 29(37):6342-51. PubMed ID: 21600951
    [Abstract] [Full Text] [Related]

  • 9. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2).
    Duan XZ, He HX, Zhuang H.
    J Gastroenterol Hepatol; 2006 Jun 26; 21(6):970-6. PubMed ID: 16724980
    [Abstract] [Full Text] [Related]

  • 10. Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model.
    Bourgine M, Dion S, Godon O, Guillen G, Michel ML, Aguilar JC.
    Virology; 2012 Aug 15; 430(1):10-9. PubMed ID: 22591777
    [Abstract] [Full Text] [Related]

  • 11. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
    Zheng BJ, Zhou J, Qu D, Siu KL, Lam TW, Lo HY, Lee SS, Wen YM.
    J Viral Hepat; 2004 May 15; 11(3):217-24. PubMed ID: 15117323
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation.
    Furukawa S, Akbar SM, Hasebe A, Horiike N, Onji M.
    J Gastroenterol; 2004 Sep 15; 39(9):851-8. PubMed ID: 15565404
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C, Peng G, Jin X, Tang J, Chen Z.
    Clin Immunol; 2010 Nov 15; 137(2):190-8. PubMed ID: 20692873
    [Abstract] [Full Text] [Related]

  • 16. [The characteristic of T cells response to HBV-specific antigen proteins in patients with HBV infection].
    Feng X, Yan HP, Liao HY, Liu YM, Zhang GY, Lin F, Zhao Y, Huang YL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug 15; 26(4):253-5. PubMed ID: 23189836
    [Abstract] [Full Text] [Related]

  • 17. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z, Kong X, Li F, Wei H, Sun R, Tian Z.
    J Immunol; 2013 Oct 15; 191(8):4184-93. PubMed ID: 24048897
    [Abstract] [Full Text] [Related]

  • 18. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L, Tian YJ, Shen H, Zhao XP, Yang DL.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 15; 17(4):275-9. PubMed ID: 19403026
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y, Guidotti LG, Fowler P, Chisari FV.
    J Immunol; 1998 Nov 01; 161(9):4520-9. PubMed ID: 9794377
    [Abstract] [Full Text] [Related]

  • 20. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
    Wang S, Han Q, Zhang N, Chen J, Liu Z, Zhang G, Li Z.
    Immunol Lett; 2010 Jan 04; 127(2):143-9. PubMed ID: 19883689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.